Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry

Abstract

According to current AF guidelines, NOACs are adequate alternatives to VKA for thromboembolic prevention in AF patients undergoing elective cardioversion. Our results indicate that NOAC use is increasing and there is a significant decrease in VKA use.